Robert N. Adams

2.7k total citations
32 papers, 2.1k citations indexed

About

Robert N. Adams is a scholar working on Neurology, Infectious Diseases and Oncology. According to data from OpenAlex, Robert N. Adams has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 9 papers in Infectious Diseases and 9 papers in Oncology. Recurrent topics in Robert N. Adams's work include Myasthenia Gravis and Thymoma (21 papers), Peripheral Neuropathies and Disorders (12 papers) and Antifungal resistance and susceptibility (8 papers). Robert N. Adams is often cited by papers focused on Myasthenia Gravis and Thymoma (21 papers), Peripheral Neuropathies and Disorders (12 papers) and Antifungal resistance and susceptibility (8 papers). Robert N. Adams collaborates with scholars based in United States, Switzerland and Sweden. Robert N. Adams's co-authors include Daniel B. Drachman, Alan Pestronk, David R. Cornblath, Caroline Angus, Steven G. Self, Gary J. Hoffman, James D. Michelson, Kathy Alderson, Amjad A. Ilyas and Hiroko Baba and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert N. Adams

32 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert N. Adams United States 19 1.6k 498 367 272 259 32 2.1k
Maartje G. Huijbers Netherlands 20 2.1k 1.3× 337 0.7× 491 1.3× 202 0.7× 183 0.7× 40 2.6k
Charles E. Thirkill United States 25 1.1k 0.7× 105 0.2× 740 2.0× 297 1.1× 117 0.5× 65 2.2k
Judith Cossins United Kingdom 25 1.2k 0.7× 121 0.2× 581 1.6× 97 0.4× 29 0.1× 47 1.8k
Premkumar Christadoss United States 35 2.2k 1.4× 61 0.1× 299 0.8× 867 3.2× 666 2.6× 106 3.2k
Simon Hawke Australia 20 316 0.2× 119 0.2× 882 2.4× 195 0.7× 167 0.6× 39 1.5k
N. B. Rewcastle Canada 23 372 0.2× 119 0.2× 567 1.5× 76 0.3× 316 1.2× 33 2.0k
Judy Cossins United Kingdom 11 584 0.4× 95 0.2× 424 1.2× 93 0.3× 29 0.1× 12 1.4k
Michael J. Dobersen United States 20 184 0.1× 177 0.4× 460 1.3× 321 1.2× 218 0.8× 35 1.5k
Anna Brunn Germany 28 799 0.5× 140 0.3× 393 1.1× 285 1.0× 199 0.8× 84 2.0k
C Laterre Belgium 13 278 0.2× 135 0.3× 256 0.7× 54 0.2× 123 0.5× 27 740

Countries citing papers authored by Robert N. Adams

Since Specialization
Citations

This map shows the geographic impact of Robert N. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert N. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert N. Adams more than expected).

Fields of papers citing papers by Robert N. Adams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert N. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert N. Adams. The network helps show where Robert N. Adams may publish in the future.

Co-authorship network of co-authors of Robert N. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Robert N. Adams. A scholar is included among the top collaborators of Robert N. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert N. Adams. Robert N. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Wenji, Robert N. Adams, Alexei Miagkov, et al.. (2012). Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: The Guided Missile strategy. Journal of Neuroimmunology. 251(1-2). 25–32. 5 indexed citations
2.
Drachman, Daniel B., Robert N. Adams, Rong Hu, Richard J. Jones, & Robert A. Brodsky. (2008). Rebooting the Immune System with High‐Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis. Annals of the New York Academy of Sciences. 1132(1). 305–314. 76 indexed citations
3.
Zhou, Lan, John McConville, Vinay Chaudhry, et al.. (2004). Clinical comparison of muscle‐specific tyrosine kinase (MuSK) antibody‐positive and ‐negative myasthenic patients. Muscle & Nerve. 30(1). 55–60. 93 indexed citations
4.
Drachman, Daniel B., et al.. (2003). Specific Immunotherapy of Experimental Myasthenia by Genetically Engineered APCs. Annals of the New York Academy of Sciences. 998(1). 520–532. 9 indexed citations
5.
Kuncl, Ralph W., Masako M. Bilak, Susan W. Craig, & Robert N. Adams. (2003). Exocytotic “constipation” is a mechanism of tubulin/lysosomal interaction in colchicine myopathy. Experimental Cell Research. 285(2). 196–207. 24 indexed citations
6.
Lobito, Adrian A., Marcela F. Lopes, Alexei Miagkov, et al.. (2002). T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor. European Journal of Immunology. 32(7). 2055–2055. 3 indexed citations
7.
Wu, Bo, Jianming Wu, Alexei Miagkov, et al.. (2001). Specific Immunotherapy by Genetically Engineered APCs: The “Guided Missile” Strategy. The Journal of Immunology. 166(7). 4773–4779. 18 indexed citations
8.
Wu, Bo, et al.. (2001). Specific Immunotherapy of Experimental Myasthenia Gravis in Vitro: The “Guided Missile” Strategy. Cellular Immunology. 208(2). 137–147. 12 indexed citations
9.
Drachman, Daniel B., Seiichi Okumura, Robert N. Adams, & Kevin R. McIntosh. (1996). Oral Tolerance in Myasthenia Gravisa. Annals of the New York Academy of Sciences. 778(1). 258–272. 35 indexed citations
10.
Cole, Andrew J., et al.. (1994). Cholinergic stimulation of skeletal muscle cells induces rapid immediate early gene expression: role of intracellular calcium. Molecular Brain Research. 26(1-2). 55–60. 15 indexed citations
11.
Kuncl, Ralph W., D. B. Drachman, Robert N. Adams, & Mohamed Lehar. (1993). 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.. Journal of Pharmacology and Experimental Therapeutics. 267(2). 582–589. 11 indexed citations
12.
Kuncl, Ralph W., Robert N. Adams, Alan Pestronk, et al.. (1993). A Novel Therapy for Myasthenia Gravis by Reducing the Endocytosis of Acetylcholine Receptorsa. Annals of the New York Academy of Sciences. 681(1). 298–302. 6 indexed citations
13.
Lillehoj, Erik P., et al.. (1990). Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide. Journal of Clinical Microbiology. 28(12). 2653–2658. 57 indexed citations
14.
Pestronk, Alan, et al.. (1989). Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Annals of Neurology. 25(1). 98–102. 85 indexed citations
15.
Pestronk, Alan, Robert N. Adams, Ralph W. Kuncl, et al.. (1989). Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders. Neurology. 39(5). 628–628. 30 indexed citations
16.
Pestronk, Alan, David R. Cornblath, Amjad A. Ilyas, et al.. (1988). A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Annals of Neurology. 24(1). 73–78. 463 indexed citations
17.
Kuncl, Ralph W., Daniel B. Drachman, & Robert N. Adams. (1988). Inhibition of methyltransferase reduces the turnover of acetylcholine receptors.. Proceedings of the National Academy of Sciences. 85(11). 4032–4036. 10 indexed citations
18.
Pestronk, Alan, et al.. (1983). Combined short‐term immunotherapy for experimental autoimmune myasthenia gravis. Annals of Neurology. 14(2). 235–241. 47 indexed citations
19.
Drachman, Daniel B., et al.. (1982). Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia Gravis. New England Journal of Medicine. 307(13). 769–775. 295 indexed citations
20.
Pearson, Thomas A., Kevin Jon Williams, Jon A. Wolff, et al.. (1979). Clonal Characteristics of Experimentally Induced "Atherosclerotic" Lesions in the Hybrid Hare. Science. 206(4425). 1423–1425. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maartje G. Huijbers Breakdown of academic impact, for papers by Charles E. Thirkill Breakdown of academic impact, for papers by Judith Cossins Breakdown of academic impact, for papers by Premkumar Christadoss Breakdown of academic impact, for papers by Simon Hawke Breakdown of academic impact, for papers by N. B. Rewcastle Breakdown of academic impact, for papers by Judy Cossins Breakdown of academic impact, for papers by Michael J. Dobersen Breakdown of academic impact, for papers by Anna Brunn Breakdown of academic impact, for papers by C Laterre
Rankless by CCL
2026